1 Min Read
April 5 (Reuters) - Neothetics Inc:
* Neothetics Inc says issuance by USPTO of eighth patent directed to lipo-202 lead clinical asset Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.